A number of other research firms have also issued reports on RB. Credit Suisse Group set a GBX 7,700 ($94.32) price objective on Reckitt Benckiser Group in a research note on Wednesday, March 30th. Deutsche Bank Rese… set a GBX 7,200 ($88.19) target price on Reckitt Benckiser Group in a research note on Thursday, May 26th. Berenberg Bank set a GBX 7,700 ($94.32) target price on Reckitt Benckiser Group in a research note on Tuesday, May 3rd. JPMorgan Chase & Co. set a GBX 8,500 ($104.12) target price on Reckitt Benckiser Group in a research note on Wednesday, April 27th. Finally, Barclays set a GBX 9,300 ($113.91) target price on Reckitt Benckiser Group in a research note on Tuesday, May 3rd.
Reckitt Benckiser Group has a 1 year low of GBX 5,782 ($70.82) and a 1 year high of GBX 8,020 ($98.24). The company has a debt-to-equity ratio of 116.01, a quick ratio of 0.53 and a current ratio of 0.77. The company has a market capitalization of £48.36 billion and a price-to-earnings ratio of 40.79.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
- NXP Semiconductors: Strong Earnings & New Microcontrollers for Electric Vehicles
- Lithium Stocks Are Offering Unprecedented Opportunity To Investors
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.